Middle East Healthcare Crecimiento futuro
Future controles de criterios 5/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Middle East Healthcare de 21.4% y 10.1% por año respectivamente. Se prevé que el BPA crezca en un 19.5% al año. Se espera que la rentabilidad financiera sea de 22.1% en 3 años.
Información clave
21.4%
Tasa de crecimiento de los beneficios
19.5%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 15.2% |
| Tasa de crecimiento de los ingresos | 10.1% |
| Rentabilidad financiera futura | 22.1% |
| Cobertura de analistas | Low |
| Última actualización | 15 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 09Recent updates
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist
Sep 24Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 09Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings
Jul 18There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital
May 30Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 09If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity
Apr 29Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge
Apr 02There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump
Feb 11Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled
Feb 08Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?
Jan 18Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors
Dec 28Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends
Sep 26Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Jun 28Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Mar 30Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal
Sep 20Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)
Jun 14Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture
Apr 18Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Aug 10Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends
Mar 29An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued
Mar 03Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 10Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock
Jan 23If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%
Jan 05Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?
Dec 18Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)
Nov 30Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 3,682 | 383 | 325 | 475 | 4 |
| 12/31/2025 | 3,319 | 297 | 151 | 415 | 4 |
| 12/31/2024 | 2,932 | 230 | 28 | 444 | 2 |
| 9/30/2024 | 2,854 | 211 | 203 | 665 | N/A |
| 6/30/2024 | 2,793 | 203 | -23 | 196 | N/A |
| 3/31/2024 | 2,704 | 182 | 69 | 270 | N/A |
| 12/31/2023 | 2,653 | 180 | -41 | 191 | N/A |
| 9/30/2023 | 2,551 | 177 | 23 | 282 | N/A |
| 6/30/2023 | 2,393 | 135 | 63 | 346 | N/A |
| 3/31/2023 | 2,276 | 105 | -95 | 172 | N/A |
| 12/31/2022 | 2,152 | 75 | -174 | 76 | N/A |
| 9/30/2022 | 2,033 | 24 | -292 | 9 | N/A |
| 6/30/2022 | 2,019 | 27 | -309 | 1 | N/A |
| 3/31/2022 | 1,968 | 26 | -259 | 114 | N/A |
| 12/31/2021 | 1,873 | 17 | -341 | 77 | N/A |
| 9/30/2021 | 1,823 | 45 | -434 | -37 | N/A |
| 6/30/2021 | 1,816 | 66 | -580 | -160 | N/A |
| 3/31/2021 | 1,733 | 73 | -501 | -166 | N/A |
| 12/31/2020 | 1,751 | 82 | -524 | -229 | N/A |
| 9/30/2020 | 1,708 | 110 | -507 | -182 | N/A |
| 6/30/2020 | 1,603 | 108 | -348 | -23 | N/A |
| 3/31/2020 | 1,583 | 104 | -440 | -38 | N/A |
| 12/31/2019 | 1,497 | 98 | -373 | 99 | N/A |
| 9/30/2019 | 1,401 | 91 | -351 | 133 | N/A |
| 6/30/2019 | 1,353 | 78 | -335 | 180 | N/A |
| 3/31/2019 | 1,346 | 100 | -289 | 164 | N/A |
| 12/31/2018 | 1,391 | 172 | -197 | 159 | N/A |
| 9/30/2018 | 1,445 | 224 | -39 | 317 | N/A |
| 6/30/2018 | 1,459 | 269 | N/A | 204 | N/A |
| 3/31/2018 | 1,464 | 297 | N/A | 135 | N/A |
| 12/31/2017 | 1,462 | 319 | N/A | 347 | N/A |
| 9/30/2017 | 1,503 | 322 | N/A | 370 | N/A |
| 6/30/2017 | 1,529 | 356 | N/A | 256 | N/A |
| 3/31/2017 | 1,588 | 368 | N/A | 453 | N/A |
| 12/31/2016 | 1,616 | 363 | N/A | 253 | N/A |
| 9/30/2016 | 1,629 | 380 | N/A | 72 | N/A |
| 6/30/2016 | 1,602 | 371 | N/A | 313 | N/A |
| 3/31/2016 | 1,564 | 389 | N/A | 303 | N/A |
| 12/31/2015 | 1,535 | 390 | N/A | 194 | N/A |
| 9/30/2015 | 1,485 | 373 | N/A | 434 | N/A |
| 6/30/2015 | 1,456 | 356 | N/A | 383 | N/A |
| 3/31/2015 | 1,431 | 357 | N/A | 253 | N/A |
| 12/31/2014 | 1,399 | 332 | N/A | 349 | N/A |
| 12/31/2013 | 828 | 137 | N/A | 129 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (21.4% al año) de 4009 es superior a la tasa de ahorro (14.7%).
Beneficios vs. Mercado: Se prevé que los beneficios (21.4% al año) de 4009 crezcan más rápidamente que el mercado SA (6.5% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de 4009 crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (10.1% al año) de 4009 crezcan más rápidamente que los del mercado SA (-0.2% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 10.1% al año) de 4009 crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de 4009 sea alta dentro de 3 años (22.1%)